CYD-X® Codling Moth Virus Available in Ample Quantities in 2005
“Supplies of CYD-X insecticidal virus are “ample” this year and should meet the needs of apple and pear growers who use the biological for control of codling moth, announced CYD-X manufacturer Certis USA. The availability of insecticidal viruses has become critical in the last two years as more producers have used the products to forestall resistance to traditional chemistries. Once viewed as organic-only pesticides, insecticidal virus users are estimated to be 70 percent conventional growers and 30 percent organic producers.
CYD-X contains a naturally occurring virus (Cydia pomonella granulovirus or CpGV) that infects and kills larvae of the codling moth. CpGV is extremely virulent to codling moth making it effective at low use rates. Studies show larvae need only ingest one or two viral protein occlusion bodies (OBs) to cause a lethal infection. A single ounce of CYD-X contains nearly one trillion OBs. CpGV is also highly specific to codling moth, so it is noninfectious to beneficial insects, fish, wildlife, livestock or humans.
Click here for more information about CYD-X.
Headquartered in Columbia, MD, Certis USA manufactures and distributes crop protection products that fill specialty niches in the horticultural and agricultural markets. Certis USA product brands include two insecticidal viruses in addition to CYD-X— GemStar® and Spod-X®--as well as, Agree®, Condor®, CryMax®, Deliver®, Javelin® and Lepinox® bioinsecticides; Azatin® and Neemix® botanical insect growth regulators; Triact® and Trilogy® botanical fungicide/miticide; Soilgard® and microbial fungicide. Certis USA is a subsidiary of Mitsui & Co., Ltd., Japan’s largest trading company. Mitsui has worldwide annual sales of $130 billion through diversified businesses in more than 90 countries. Mitsui also markets and distributes crop protection products and services directly and through its marketing subsidiaries in Europe, Japan, Africa and the U.S. Its global crop protection sales exceed $500 million annually.